Ambrox Purification via Enzymatic Cyclization and Crystallization

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for producing (-)-Ambrox, a valuable fragrance ingredient, lack industrially scalable and cost-effective processes, particularly in obtaining olfactively pure form, due to challenges in sourcing pure 7E,3E-homofarnesol and efficient bioconversion methods.

Innovation Solution

A bioconversion process using a recombinant microorganism expressing Squalene Hopene Cyclase (SHC) enzyme to convert a mixture of 7E,3E/Z-homofarnesol to (-)-Ambrox, followed by selective crystallization for purification, allowing for the production of (-)-Ambrox in olfactively pure form with facile downstream processing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If synthetic methods are used to produce (-)-Ambrox from natural starting materials, then the production can be carried out with available materials, but the cost increases and availability decreases due to dependency on natural resources and climatic conditions

Engineering Contradiction:

Improveavailability of starting materialsVSAvoidproduction cost

Core Design Contradiction:

Ease of manufactureVSProductivity

Solution Approach 1:

The patent replaces traditional chemical synthesis methods with a biocatalytic system using Squalene Hopene Cyclase enzyme. This biological system converts homofarnesol to (-)-Ambrox through enzymatic cyclization, eliminating the need for complex multi-step chemical synthesis and dependency on natural resource extraction, thereby reducing costs and improving sustainability

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the fundamental parameter of the production system from chemical synthesis to biological catalysis. By using recombinant microorganisms expressing SHC enzyme, the process achieves higher specificity, milder reaction conditions, and reduced waste, directly addressing the cost and availability issues of traditional synthetic methods

Inventive Principle:

Principle #35Parameter changes

2Object-generated harmful factors

If bioconversion using Squalene Hopene Cyclase is used to convert homofarnesol to (-)-Ambrox, then a potentially less complex and less polluting process is achieved, but the challenge of obtaining olfactively pure form and efficient downstream processing remains

Engineering Contradiction:

ImprovepollutionVSAvoiddownstream processing complexity

Core Design Contradiction:

Object-generated harmful factorsVSDevice complexity

Solution Approach 1:

The patent employs preliminary action by using enzyme engineering to optimize SHC catalyst specificity before the bioconversion step. By designing and selecting enzyme variants with enhanced stereoselectivity and substrate specificity, the reaction produces (-)-Ambrox with higher purity and fewer by-products, thereby simplifying subsequent downstream processing operations

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent introduces an engineered SHC enzyme as an intermediary that mediates the conversion of homofarnesol to (-)-Ambrox. This biocatalyst acts as a selective intermediary that transforms the substrate into the desired product with high specificity, reducing the formation of unwanted by-products and simplifying purification requirements

Inventive Principle:

Principle #24Intermediary (Mediator)

3Productivity

If pure 7E,3E-homofarnesol is used as substrate for bioconversion, then the yield of (-)-Ambrox can be maximized, but the cost and availability of this pure substrate become limiting factors

Engineering Contradiction:

Improveyield of (-)-AmbroxVSAvoidcost of substrate

Core Design Contradiction:

ProductivityVSEase of manufacture

Solution Approach 1:

The patent applies local quality by using enzyme engineering to create SHC variants with enhanced substrate scope and tolerance. The engineered enzyme maintains high catalytic efficiency and stereoselectivity even when applied to less pure or more economically available homofarnesol substrates, thereby decoupling substrate purity requirements from product yield

Inventive Principle:

Principle #3Local quality

Solution Approach 2:

The patent achieves universality by developing SHC enzyme variants that can effectively process a broader range of homofarnesol substrates. The engineered enzyme exhibits multi-functional capability, maintaining high activity and selectivity across different substrate qualities and purities, making the process robust and economically viable

Inventive Principle:

Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enables the production of (-)-Ambrox in olfactively pure form with high yields, facilitating cost-effective and industrially scalable production, addressing the limitations of previous methods by providing a viable route for obtaining this fragrance ingredient.

Implementation Method 1

The homofarnesol mixture is converted to (-)-Ambrox and its 9-epi stereoisomer, and purification can be carried out by distillation or by column chromatography

Methodology Applied

Scientific EffectEnzymatic catalysis: Enzyme